Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with One Year of IDegAsp Therapy in Poorly Controlled and Non-compliant Patients

INTRODUCTION: To evaluate the efficacy of degludec/aspart (IDegAsp) insulin co-formulation in children and adolescents with poorly controlled type 1 diabetes (T1DM). METHODS: Patients with poorly controlled T1DM on basal-bolus insulin regimes and having compliance problems related to insulin injecti...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Tarık Kırkgöz, Mehmet Eltan, Sare Betül Kaygusuz, Zehra Yavaş Abalı, Didem Helvacıoğlu, Tuba Seven Menevşe, Büşra Gürpınar Tosun, Tülay Güran, Abdullah Bereket, Serap Demircioğlu
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Pediatric Endocrinology and Diabetes Society 2022-03-01
Rangatū:	JCRPE
Ngā marau:	type 1 diabetes mellitus hypoglycemia diabetic ketoacidosis co-formulation insulin degludec insulin aspart idegasp
Urunga tuihono:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=jcrpe&un=JCRPE-52533
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!